Cellular Immunotherapy Market Size, Share, Growth 2035


What Growth Rate And Market Size Expansion Are Predicted For The Cellular Immunotherapy Market Across The Forecast Period?
The cellular immunotherapy market size has grown rapidly in recent years. It will grow from $6.56 billion in 2025 to $7.48 billion in 2026 at a compound annual growth rate (CAGR) of 14.1%. The growth in the historic period can be attributed to success of early car-t therapies, unmet oncology needs, research funding growth, regulatory approvals, academic-industry collaboration.

The cellular immunotherapy market size is expected to see rapid growth in the next few years. It will grow to $12.5 billion in 2030 at a compound annual growth rate (CAGR) of 13.7%. The growth in the forecast period can be attributed to expansion into solid tumors, innovation in nk cell therapy, scalable manufacturing technologies, supportive regulatory frameworks, increased oncology investment. Major trends in the forecast period include rapid growth of car-t cell therapies, expansion of allogeneic cell therapies, increasing use in hematologic malignancies, advancements in t cell engineering, rising clinical trial activity.

Claim Your Free Report Sample Today:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3435&type=smp

What Drivers Are Contributing To The Expansion Trajectory Of The Cellular Immunotherapy Market?
The rising prevalence of cancer is expected to propel the growth of the cellular immunotherapy market going forward. Cancer is a group of diseases characterized by the uncontrolled growth and spread of abnormal cells in the body. The rising prevalence of cancer is largely due to an aging population, lifestyle factors, and improved screening and diagnosis. Environmental exposures and genetic predispositions also play significant roles in increasing incidence rates. Cellular immunotherapy boosts the immune response against cancer by specifically targeting tumor cells, improving survival rates. This approach, combined with other treatments, may lead to a decrease in cancer incidence and recurrence. For instance, in March 2024, according to MAC Clinical Research, a UK-based cancer research organization, the estimated number of people living with cancer in the United Kingdom is expected to increase from about 3 million currently to 3.5 million by 2025, 4 million by 2030, and 5.3 million by 2040. Therefore, the rising prevalence of cancer is driving the growth of the cellular immunotherapy market.

Which Primary Segments Are Included In The Detailed Analysis Of The Cellular Immunotherapy Market?
The cellular immunotherapy market covered in this report is segmented –

1) By Therapy: Tumor-Infiltrating Lymphocyte (TIL) Therapy, Engineered T Cell Receptor (TCR) Therapy, Chimeric Antigen Receptor (CAR) T Cell Therapy, Natural Killer (NK) Cell Therapy
2) By Primary Indication: B-cell Malignancies, Prostate Cancer, Renal Cell Carcinoma, Liver Cancer, Non-Hodgkin lymphoma, Other Primary Indications
3) By Application: Prostate Cancer, Breast Cancer, Skin Cancer, Ovarian Cancer, Brain Tumor, Lung Cancer, Other Applications

Subsegments:
1) By Tumour-Infiltrating Lymphocyte (TIL) Therapy: Autologous TIL Therapy, Allogeneic TIL Therapy
2) By Engineered T Cell Receptor (TCR) Therapy: Alpha-Beta TCR Therapy, Gamma-Delta TCR Therapy
3) By Chimeric Antigen Receptor (CAR) T Cell Therapy: Autologous CAR T Cell Therapy, Allogeneic CAR T Cell Therapy, CAR T Cell Therapy For Solid Tumors, CAR T Cell Therapy For Hematologic Malignancies
4) By Natural Killer (NK) Cell Therapy: Autologous NK Cell Therapy, Allogeneic NK Cell Therapy, NK Cell Therapy With Engineered Modifications

What Trends Are Driving Change Across The Cellular Immunotherapy Market Landscape?
Major companies operating in the cellular immunotherapy market are focused on developing technological advancements such as immunotherapy. To enhance treatment efficacy and expand applications. Their focus includes personalized medicine, combination therapies, and scalable manufacturing to improve patient outcomes. Immunotherapy is a treatment that harnesses the body’s immune system to fight diseases, especially cancer. It can involve boosting immune responses or providing targeted therapies to enhance immune activity against specific cells. For instance, in December 2023, Max Healthcare Institute Limited is an India-based healthcare service provider company. CAR-T cell therapy is a revolutionary cancer treatment that utilizes genetically engineered T cells to specifically target and destroy cancer cells, offering a personalized approach. It provides durable remission rates, particularly for resistant blood cancers, while minimizing damage to healthy tissues.

Which Major Corporations Play A Crucial Role In The Cellular Immunotherapy Market Landscape?
Major companies operating in the cellular immunotherapy market are Novartis International AG, Gilead Sciences Inc., Apac Biotech, Dendreon Pharmaceuticals LLC, JW CreaGene Co. Ltd, Green Cross Corp, AstraZeneca plc, Bristol Myers Squibb Company, Pfizer Inc., F. Hoffmann-La Roche Ltd., Adicet Bio Inc., ResTORbio Inc., Celyad SA, Merck KGaA, GlaxoSmithKline plc., Johnson & Johnson, Adaptimmune Therapeutics plc, AVROBIO Inc., Cellular Biomedicine Group Inc., Kite Pharma Inc., Juno Therapeutics Inc., Celgene Corporation, Bluebird Bio Inc., Tmunity Therapeutics Inc., Atara Biotherapeutics Inc., Fate Therapeutics Inc., Precision Biosciences Inc., Allogene Therapeutics Inc., CRISPR Therapeutics AG, Sangamo Therapeutics Inc., Intellia Therapeutics Inc., Editas Medicine Inc., Caribou Biosciences Inc., Mammoth Biosciences Inc., Synthego Corporation

Get Your In-Depth Cellular Immunotherapy Market Report Now:
https://www.thebusinessresearchcompany.com/report/cellulars-immunotherapy-global-market-report

Which Geographical Region Is Projected To Lead The Cellular Immunotherapy Market Throughout The Forecast Period?
North America was the largest region in the cellular immunotherapy market in 2025. The regions covered in the cellular immunotherapy market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Contact Us:

The Business Research Company: https://thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email: info@tbrc.info

Follow Us On:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

Comments

Post a Comment

Popular posts from this blog

Glycomics or Glycobiology Market Scope, Share Analysis And Growth 2025

Image
Backed by rigorous analysis and deep industry knowledge, this study is designed to support growth and investment decisions in the glycomics or glycobiology market. How Big Is The Glycomics or Glycobiology Market In 2025? The glycomics or glycobiology market size has grown rapidly in recent years. It will grow from $1.85 billion in 2024 to $2.13 billion in 2025 at a compound annual growth rate (CAGR) of 14.9%. The growth in the historic period can be attributed to increased awareness of glycans in biological systems, expansion of glycan-related database and resources, rise in collaborative research initiatives, advancements in glycan synthesis and engineering, glycan biomarker identification. The glycomics or glycobiology market size is expected to see rapid growth in the next few years. It will grow to $3.99 billion in 2029 at a compound annual growth rate (CAGR) of 17.0%. The growth in the forecast period can be attributed to glycan-focused artificial intelligence (AI) and data analy...
Read more

Hypertrophic Cardiomyopathy (HCM) Therapeutics Market Scope, Share Analysis And Growth 2025

Image
Focused on real-world business use, this report highlights what’s changing in the hypertrophic cardiomyopathy (hcm) therapeutics market and what companies should prepare for next. What Is The Projected Market Size & Growth Rate Of The Hypertrophic Cardiomyopathy (HCM) Therapeutics Market? The hypertrophic cardiomyopathy (hcm) therapeutics market size has grown marginally in recent years. It will grow from $1.34 billion in 2024 to $1.37 billion in 2025 at a compound annual growth rate (CAGR) of 1.5%. The growth in the historic period can be attributed to diagnostic advancements, increased disease awareness, drug development and approvals, rising healthcare expenditure, government initiatives and funding. The hypertrophic cardiomyopathy (hcm) therapeutics market size is expected to see steady growth in the next few years. It will grow to $1.56 billion in 2029 at a compound annual growth rate (CAGR) of 3.4%. The growth in the forecast period can be attributed to genetic research and ...
Read more

Smart Crop Monitoring Market Overview, Analysis And Demand By 2034

Image
Aimed at strategic decision-makers, this report explores current opportunities, emerging trends, and market dynamics shaping the smart crop monitoring sector. How Big Is The Smart Crop Monitoring Market In 2025? The smart crop monitoring market size has grown rapidly in recent years. It will grow from $3.47 billion in 2024 to $4.09 billion in 2025 at a compound annual growth rate (CAGR) of 18.0%. The growth in the historic period can be attributed to rising demand for high crop production, increasing global population, significant growth in IOT technology, rising need for sustainable agricultural practices, and increasing regulatory pressures. The smart crop monitoring market size is expected to see rapid growth in the next few years. It will grow to $7.83 billion in 2029 at a compound annual growth rate (CAGR) of 17.6%. The growth in the forecast period can be attributed to the development of automated irrigation systems, the growing trend of farm-to-table movements, an increase in ag...
Read more